- Anniversary/History
- Membership
- Publications
- Resources
- Education
- Events
- Outreach
- Careers
- About
- For Pain Patients and Professionals
Papers: 27 Nov 2021 - 3 Dec 2021
Animal Studies
2021 Nov 29
Mol Metab
Peripheral neuropathy is the most common and debilitating complication of type 2 diabetes leading to sensory loss, dysautonomia, hyperalgesia and spontaneous noxious sensations. Despite clinical and economic burden of diabetic neuropathy, no effective treatment is available. Thus, more preclinical research must be conducted to gain further understanding of the aetiology of the disease and elucidate new therapeutic targets.